[210 Pages Report] There is growing demand for protein expression technology in multiple industries for numerous applications such as biologics production, therapeutic protein production, and research application. The global protein expression technology market is projected to experience significant growth during the forecast period, due to the growing demand for proteomics for the identification of several proteins that …
Category Archives: Healthcare Trends
Large Molecule Bioanalytical Testing Services Market is anticipated to reach US$ 4.7 Billion by 2033
According to Future Market Insights’ newly released Large Molecule Bioanalytical Testing Service Market analysis report, the market is worth more than US$ 1.5 Billion at present. The market is expected to reach US$ 4.7 billion by 2033, with a CAGR of 12.1% from 2023 to 2033. Clinical Phase is expected to generate significant revenue, with …
Cerebral Aneurysm Management Market is expected to grow with a 6.7% CAGR during 2023 to 2033
The global cerebral aneurysm management market size is predicted to generate a market value of US$ 1.56 billion in 2023 and a market value of US$ 2.98 billion by 2023 to 2033, at a CAGR of 6.7%. The rise in the elderly population and the availability of various treatments to treat the ailment might be …
Disseminated Intravascular Coagulation Treatment Market is expected to reach US$ 814.45 million by 2033
The global Disseminated Intravascular Coagulation Treatment Market is estimated to reach US$ 500 million in 2023 and US$ 814.45 million by 2033, growing at a CAGR of 5% from 2023 to 2033. The market for Disseminated Intravascular Coagulation (DIC) Treatment grew at a 4% CAGR from 2018 to 2022. According to studies, the projected number …
North America is expected to possess 40% share for the Hypercoagulability Treatment Market
The global hypercoagulability treatment market is predicted to generate a market value of US$ 670 million in 2023 and a market value of US$ 1,317.99 million by 2033, with a CAGR of 7% from 2023 to 2033. In the historical period 2018 to 2022, the market for Hypercoagulability Treatment grew at a CAGR of 4%. …
Medication to Procure 55% Market Share for Salivary Gland Infection Treatment Market in 2023 | FMI Study
During the forecast period 2023 to 2033, the Salivary Gland Infection Treatment Market is expected to grow at a value of 9.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Salivary gland infection treatment is expected to rise up to a market valuation of US$ 12,300 Million. Growth of …
China is predicted to register a CAGR of 9.8% in the Starter Cultures Market from 2023 to 2033
The worldwide sales of starter cultures, which were previously estimated to be worth around US$ 1,123.1 million in 2022, are now expected to boost up. Currently, in the year 2023, the global Starter Cultures Market value is figured out to be around US$ 1,191.6 million. Further, it is expected to develop with a higher average …
In Vitro Diagnostics Market is projected to cross a value of US$ 129.9 Billion by 2033 at a CAGR of 4.8%
The In Vitro Diagnostics Market is likely to thrive at an average CAGR of 4.8% between 2023 and 2033. The market is anticipated to cross a market share of US$ 129.9 billion by 2033 while it is valued at US$ 81.3 billion in 2023. Advanced medical science and complex diseases are fueling the demand for …
Hernia Repair Devices Market is expected to rise a valuation of US$ 12.3 billion by 2033 at a CAGR of 9.4%
The Hernia Repair Devices Market is anticipated to be worth US$ 5.0 billion in 2023 and US$ 12.3 billion by 2033. During the projection period, sales of hernia repair devices are anticipated to grow significantly (CAGR: 9.4%). As per a recent report published by FMI, the hernia repair devices market is expected to record an average CAGR …
Secondary Myelofibrosis Therapeutics Market is expected to reach US$ 2.74 Billion grow with a 6.3% CAGR from 2023 to 2033
During the forecast period 2023 to 2033, the Secondary Myelofibrosis Therapeutics Market is expected to grow at a value of 6.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Secondary myelofibrosis therapeutics is expected to rise up to a market valuation of US$ 2.74 Billion. Growth of the market …